DRTHX
Price
$21.32
Change
-$0.20 (-0.93%)
Updated
Jul 13 closing price
Net Assets
518.69M
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

DRTHX vs VFFSX

DRTHX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
DRTHX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRTHX is a StrongBuy and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. DRTHX (519M). VFFSX pays higher dividends than DRTHX: VFFSX (1.08) vs DRTHX (0.15). DRTHX was incepted earlier than VFFSX: DRTHX (54 years) vs VFFSX (10 years). DRTHX (0.75) is less costly to investors than VFFSX (0.01). DRTHX is a more actively managed with annual turnover of: 27.23 vs. VFFSX (2.00). DRTHX has a lower initial minimum investment than VFFSX: DRTHX (1000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. DRTHX (6.34). VFFSX return over 5 years is better than : 73.48 vs. DRTHX (14.25).
DRTHXVFFSXDRTHX / VFFSX
Total Expense Ratio0.750.017,500%
Annual Report Gross Expense Ratio0.750.017,500%
Fund Existence54 years10 years-
Gain YTD8.19510.68577%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets519M1.67T0%
Annual Yield % from dividends0.151.0814%
Returns for 1 year6.3421.0730%
Returns for 3 years36.5168.4553%
Returns for 5 years14.2573.4819%
Returns for 10 years75.92251.2130%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6